Look behind the lecture: can biosimilars improve patient access in countries with restricted resources?

Written by The Evidence Base

András Inotai (Semmelweis University and Syreon Research Institute, both Budapest, Hungary) discusses his presentation from ISPOR Europe 2019 (2—6 November; Copenhagen, Denmark) on the opportunities that biosimilars offer to improve patient access in countries with restricted healthcare resources. In this feature, we take a 'look behind the lecture' with András Inotai (Semmelweis University and Syreon Research Institute; both Budapest, Hungary) as he discusses his presentation from ISPOR Europe 2019 (2—6 November; Copenhagen, Denmark) on the opportunities that biosimilars offer to improve patient access in countries with restricted healthcare resources. Please could you introduce yourself? I am an Associate Professor in...

To view this content, please register now for access

It's completely free